Droxidopa in Critical Care: A Systematic Review of an Emerging Off‐Label Practice
Available evidence on droxidopa for vasopressor weaning in ICU patients remains limited and heterogeneous, with very low certainty. Further research is warranted. No funding was received for this review, and the review was not prospectively registered.
Authors
- Katherine Chiapaikeo-Poco (ORCID: https://orcid.org/0009-0001-3583-3446)
- Carlos Valladares (ORCID: https://orcid.org/0000-0001-9176-3510)
- Marc Faltas (ORCID: https://orcid.org/0009-0007-2772-4008)
- Franklyn Vega Batista (ORCID: https://orcid.org/0009-0004-2730-4861)
- Mareya Menteyas (ORCID: https://orcid.org/0009-0006-0742-3454)
Institutions
- University of Miami (US)
- Community Medical Center (US)
- University of Miami Hospital (US)
- Rowan University (US)
Publication Details
- Journal
- Critical Care Research and Practice
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1155/ccrp/4830160
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00